Tag: ASX

The Australian psychedelic-assisted therapy provider has reported record quarterly revenue of $1.42 million, expanded its national clinic network and received ...

Entropy Neurodynamics has reported sustained improvements in treatment-resistant binge-eating disorder three months after patients received two infusions of its IV ...

Australia's listed cannabis sector has become increasingly difficult to define simply as "cannabis". The latest results show companies moving in ...

BLS Pharmaceuticals (ASX: BLS) has reported a record FY26, with revenue climbing 161% to $74.2 million and Adjusted EBITDA rising ...

For much of the past decade, Australia's medicinal cannabis industry has been defined by domestic growth. Companies raced to expand ...

BLS Pharmaceuticals (ASX: BLS) has signed a referral agreement with US-based Cayman Chemical Company, expanding its international commercial network for ...

Australia has earned global recognition for its role in the emerging psychedelic medicines sector. The country's decision to permit authorised ...

Australian biotechnology company Entropy Neurodynamics (ASX: ENP) has reported encouraging topline results from the first cohort of its Phase 2 ...